Cytometry Part B-Clinical Cytometry

Article	Citations
Issue highlights—January 2025	31
The role of the primitive marker CD133 in CD34‐negative acute myeloid leukemia for the detection of leukemia stem cells	30
	29
Erythroid side scatter: A parameter that improves diagnostic accuracy of flow cytometry myelodysplastic syndrome scoring	27
Mass cytometric single cell immune profiles of peripheral blood from acute myeloid leukemia patients in complete remission with measurable residual disease	23
Issue highlights—September 2023	18
	17
Issue Information	16
	15
Standardization of flow cytometric detection of antigen expression	14
Issue Information	14
Validation of a new multiparametric protocol to assess viability, acrosome integrity and mitochondrial activity in cooled and frozen thawed boar spermatozoa	12
Utility of leukocyte‐associated immunoglobulin‐like receptor‐1 (CD305) in flow cytometric detection of minimal bone marrow involvement by B‐cell non‐Hodgkin lymphoma	12
Machine learning optimized multiparameter radar plots for B‐cell acute lymphoblastic leukemia minimal residual disease analysis	11
Issue Information	11
Phenotype and oxidative burst of low‐density neutrophil subpopulations are altered in common variable immunodeficiency patients	11
Addition of CD14 improves discrimination of lymphocytes in the TBNK phenotyping panel	11
CD133 in T‐lymphoblastic leukemia is preferentially expressed in early T‐phenotype (ETP) and near ETP subtypes	10
Issue Highlights—January 2022	10
Issue Information	10
Abnormal B‐lymphoblasts in myelodysplastic syndromes and myeloproliferative neoplasms other than chronic myeloid leukemia	10
Issue Information	9
Issue Information	9
	9
Increased TOX expression concurrent with PD‐1, Tim‐3, and CD244 expression in T cells from patients with acute myeloid leukemia	9

Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS‐Flow	9
ROR1 expression in mature B lymphoid neoplasms by flow cytometry	9
Converting an HLA‐B27 flow assay from the BD FACSCanto to the BD FACSLyric	9
Whole blood no‐lyse no‐wash micromethod for the quantitative measurement of monocyte HLA‐DR	9
SingletSeeker: an unsupervised clustering approach for automated singlet discrimination in cytometry	8
Integration of T‐cell clonality screening using TRBC‐1 in lymphoma suspect samples by flow cytometry	8
Alignment, segmentation and neighborhood analysis in cyclic immunohistochemistry data using CASSATT	8
Performance of a novel eight‐color flow cytometry panel for measurable residual disease assessment of chronic lymphocytic leukemia	7
Correction to “Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International	7
Summary of validation considerations with real‐life examples using both qualitative and semiquantitative flow cytometry assays	7
Issue Information	6
Appropriate interpretation of TRBC1‐dim positive subsets in T‐cell immunophenotyping by flow cytometry	6
Bone marrow follicular‐like T cells in monoclonal gammopathies	6
	6
Quick identification of target antigens by tissue flow cytometry for CAR‐T therapy in B‐cell malignancies	6
Enhancing HLA‐B27 antigen detection: Leveraging machine learning algorithms for flow cytometric analysis	6
	6
Imaging flow cytometry reveals a subset of TdT negative T‐ALL blasts with very low forward scatter on conventional flow cytometry	6
Clinical significance of end of induction measurable residual disease monitoring in B‐cell acute lymphoblastic leukemia: A single center experience	5
Automated analysis of flow cytometry data with minimal training files: Research evaluation of an elastic image registration algorithm for TBNK, stem cell enumeration, and lymphoid screening	5
	5
Editorial on IVD cellular assay validation	5
Extranodal NK/T‐cell lymphoma with isolated central nervous system relapse: A defiant disease and the role of flow cytometry in monitoring	5
Monocyte HLA‐DR expression as an enrollment biomarker in sepsis clinical trials: Evaluation of two sampling tubes and definition of respective clinical thresholds	5
Possible alternative strategies to implement basophil activation testing in multicentric studies	5
Flow cytometric analysis of myelodysplasia: Pre‐analytical and technical issues—Recommendations from the European LeukemiaNet	4
Implementation of beaker CP for flow cytometry: Workflow optimization and integration at Stanford Health Care	4
Intraoperative flow cytometry in detecting free carcinoma cells in peritoneal lavage fluid of gastric carcinoma cases	4
Patients without cutaneous T‐cell lymphoma frequently harbor CD4 T‐lymphocytes that lack CD26 and/or CD7	4
Issue Highlights—July 2022	4
Glucose‐6‐phosphate dehydrogenase deficiency detection using fluorocytometric assay: Evaluation after 1 year of clinical implementation	4
CD38, CD39, and BCL2 differentiate disseminated forms of high‐grade B‐cell lymphomas in biological fluids from Burkitt lymphoma and diffuse large B‐cell lymphoma	4
The patterns and diagnostic significance of the lack of surface immunoglobulin light chain on mature B cells in clinical samples for lymphoma workup	4
Remembering Dr. Bruce H. Davis: A passionate leader in clinical flow cytometry	4
Bicentric evaluation of stabilizing sampling tubes for assessment of monocyte HLA‐DR expression in clinical samples	4
	3
Flow cytometric immunophenotyping of plasma cells across the spectrum of plasma cell proliferative disorders: A fresh insight with pattern‐based recognition	3
	3
Expression levels and patterns of B‐cell maturation antigen in newly diagnosed and relapsed multiple myeloma patients from Indian subcontinent	3
Translating the regulatory landscape of medical devices to create fit‐for‐purpose artificial intelligence (AI) cytometry solutions	3
28‐color single tube for flow cytometric assessment of myeloid maturation, myeloid neoplasia, and acute myeloid leukemia minimal/measurable residual disease	3
Issue Highlights—November 2021	3
Issue highlights—November 2024	3
	3
Issue Highlights—March 2022	3
Use of flow cytometry and cytology to differentiate breast implant‐associated anaplastic large cell lymphoma from reactive seromas in Brazilian patients	3
Prospective feasibility of a minimal BH3 profiling assay in acute myeloid leukemia	3
A lasso and random forest model using flow cytometry data identifies primary myelofibrosis	3
Flow cytometric immunophenotypic differentiation patterns of bone marrow eosinophilopoiesis	3
PD‐1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndrome	3

Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry	3
Hierarchical clustering of clinical and flow cytometry parameters is associated with deterioration in patients with community‐acquired pneumonia in the emergency department: A preliminary study	3
Flow cytometric analysis of CD34+CD38− cells; cell frequency and immunophenotype based on CD45RA expression pattern	3
Issue highlights—July 2024	3
Increased IFN‐γ+ and TNF‐α+ mucosal‐associated invariant T cells in patients with aplastic anemia	3
Spurious CD34 expression in B‐cell lymphoma due to nonspecific binding to PerCP‐Cy5.5 fluorochrome conjugates: A rare phenomenon and a diagnostic pitfall	2
	2
The use of erythrocytes as biomarkers with a timeline	2
Flow cytometry in the diagnosis of myelodysplastic syndromes	2
Recommendations for using artificial intelligence in clinical flow cytometry	2
Issue highlights—July 2023	2
Issue Information	2
The role of CD20+ T cells: Insights in human peripheral blood	2
European flow cytometry quality assurance guidelines for the diagnosis of primary immune deficiencies and assessment of immune reconstitution following B cell depletion therapies and transp	2
Differentiating reactive and neoplastic gamma‐delta (γδ) T‐cell expansions in the peripheral blood and bone marrow	2
A series of case studies illustrating the role of flow cytometry in the diagnostic work‐up of myelodysplastic syndromes	2
Myeloid sarcoma or mixed phenotype acute leukemia? Multiparametric flow cytometry to the rescue in an unusual diagnostic dilemma	2
Role of flow cytometric immunophenotyping in the diagnosis of breast implant‐associated anaplastic large cell lymphoma: A 6‐year, single‐institution experience	2
Concomitant cutaneous T‐cell lymphoma and biclonal B‐cell lymphoproliferative disorder	2
Issue Information	2
Correlation between a 10‐color flow cytometric measurable residual disease (MRD) analysis and molecular MRD in adult B‐acute lymphoblastic leukemia	2
Flow cytometric assessment for minimal/measurable residual disease in B lymphoblastic leukemia/lymphoma in the era of immunotherapy	2
Automated quantification of measurable residual disease in chronic lymphocytic leukemia using an artificial intelligence‐assisted workflow	2
Flow cytometry for meningeal infiltration in B acute lymphoblastic leukemia in a low middle income country	2
Optimization of monocyte gating to quantify monocyte subsets for the diagnosis of chronic myelomonocytic leukemia	2
Where diagnosis for myelodysplastic neoplasms (MDS) stands today and where it will go: The role of flow cytometry in evaluation of MDS	2
Validation of a 12‐color flow cytometry assay for acute myeloid leukemia minimal/measurable residual disease detection	2
Issue Information	2
Issue highlights—September 2024	2
A comparison and review of the flow cytometric findings in classic Hodgkin lymphoma, nodular lymphocyte predominant Hodgkin lymphoma, T cell/histiocyte rich large B cell lymphoma, and primary mediasti	2
Use of a hybrid intelligence decision tree to identify mature B‐cell neoplasms	2
Issue highlights—May 2023	2
Urinary red blood cell‐derived microparticles and phosphatidylserine‐exposing red blood cells in glomerular and non‐glomerular hematuria patients	2
Noel Warner Ph.D.	2
Analytical assay validation for acute myeloid leukemia measurable residual disease assessment by multiparametric flow cytometry	2
Issue Highlights—September 2022	2
	2
Clinical, immunophenotypic, and cytogenetic characteristics of high‐grade myelodysplastic syndromes with CD41‐positive progenitor cells	2
	1
Transient abnormal lymphomyelopoiesis in a newborn with PTPN11 mutation associated Noonan syndrome	1
Issue highlights—February 2024	1
Issue highlights—May 2024	1
B‐lineage antigens that are useful to substitute CD19 for minimal residual disease monitoring in B cell precursor acute lymphoblastic leukemia after CD19 targeting	1
Dissecting the sCD3‐CD4+ T‐cell population: A valuable screening tool for angioimmunoblastic T‐cell lymphoma	1
Comparison of three machine learning algorithms for classification of B‐cell neoplasms using clinical flow cytometry data	1
	1
Issue Highlights—May 2022	1
Cross‐sectional reassessment after 4 years of clinical routine use of AQUIOS CL for absolute T cell quantitation in a university hospital	1
IgE‐mediated bleomycin hypersensitivity: Evidence from drug‐reactive T lymphocytes	1
Issue Information	1
External quality assessment of flow cytometric bronchoalveolar lavage cellular analysis: 20 years' experience in The Netherlands	1
CD5‐negative chronic lymphocytic leukemia: Does this entity really exist?	1
Automation in flow cytometry: Guidelines and review of systems	1
Longitudinal monitoring of class‐switched memory‐B cell proportions identifies plausible germinal center failure in patients with suspected immune disorders	1
Issue Information	1
Issue Information	1
Unraveling genotype–phenotype associations and predictive modeling of outcome in acute myeloid leukemia	1
Acute leukemia of ambiguous lineage, not otherwise specified with FLT3‐ITD mutation and a possible origin in the common lymphoid progenitor	1
	1
Unsupervised cluster analysis and subset characterization of abnormal erythropoiesis using the bioinformatic Flow‐Self Organizing Maps algorithm	1
Immunophenotypic portrait of leukemia‐associated‐phenotype markers in B acute lymphoblastic leukemia	1
Comparison of monoclonal antibody to CD59 for the diagnosis of paroxysmal nocturnal hemoglobinuria by flow cytometry	1
Flow cytometry of DNMT1 as a biomarker of hypomethylating therapies	1
ESCCA/ISCCA survey on the use of multicolor flow cytometry in the detection of cerebrospinal fluid involvement in hematological malignancies: How close does real‐life adhere to t	1
Flow cytometry immunophenotypic features of pure erythroid leukemia and the distinction from reactive erythroid precursors	1
Highly sensitive single tube B‐lymphoblastic leukemia/lymphoma minimal/measurable residual disease test robust to surface antigen directed therapy	1
Issue highlights—November 2022	1
	1
Dual peaks on flow cytometric DNA ploidy analysis in chronic lymphocytic leukemia with Richter transformation	1
Technical, gating and interpretation recommendations for the partitioning of circulating monocyte subsets assessed by flow cytometry	1
Immunophenotypic characteristics of ZNF384 rearrangement compared with BCR‐ABL1, KMT2A rearrangement, and other adult B‐cell precursor	1
A comprehensive 26‐color immunophenotyping panel to study the role of the gut‐liver axis in chronic liver diseases	1
Relevance of polyclonal plasma cells and post‐therapy immunomodulation in measurable residual disease assessment in multiple myeloma	1
Circulating CD22+/CD19−/CD24− progenitors and CD22+/CD19+/CD24− mature B cells: Diagnostic pitfalls for minimal residual disease detec	1
Issue Information	1
Human leukocyte antigen‐B27 typing by flow cytometry: Comparison of three CE‐IVD methods	1
Characterization of myelodysplastic syndromes hematopoietic stem and progenitor cells using mass cytometry	1
Integrated analysis of genotype and phenotype reveals clonal evolution and cytogenetically driven disruption of myeloid cell maturation in myelodysplastic syndromes	1
Maturational dyssynchrony in benign B‐cell precursors following lymphocyte depleting chemotherapy: A potential pitfall for B‐lymphoblastic leukemia minimal/measurable residual di	1
	1

	1
Comparison of a modified flow cytometry osmotic fragility test with the classical method for the diagnosis of hereditary spherocytosis	1
Clinical validation of a real‐time machine learning‐based system for the detection of acute myeloid leukemia by flow cytometry	1
Issue Highlights—September 2021	1